Clinical Trial Update: A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for TQ-B3139 capsules in MET-altered advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TQ-B3139 capsules

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN